Skip to main navigation Skip to search Skip to main content

d-Dimer elevation and adverse outcomes

  • Rim Halaby
  • , Christopher J. Popma
  • , Ander Cohen
  • , Gerald Chi
  • , Marcelo Rodrigues Zacarkim
  • , Gonzalo Romero
  • , Samuel Z. Goldhaber
  • , Russell Hull
  • , Adrian Hernandez
  • , Robert Mentz
  • , Robert Harrington
  • , Gregory Lip
  • , Frank Peacock
  • , James Welker
  • , Ignacio Martin-loeches
  • , Yazan Daaboul
  • , Serge Korjian
  • , C. Michael Gibson

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)
956 Downloads (Pure)

Abstract

d-Dimer is a biomarker of fibrin formation and degradation. While a d-dimer within normal limits is used to rule out the diagnosis of deep venous thrombosis and pulmonary embolism among patients with a low clinical probability of venous thromboembolism (VTE), the prognostic association of an elevated d-dimer with adverse outcomes has received far less emphasis. An elevated d-dimer is independently associated with an increased risk for incident VTE, recurrent VTE, and mortality. An elevated d-dimer is an independent correlate of increased mortality and subsequent VTE across a broad variety of disease states. Therefore, medically ill subjects in whom the d-dimer is elevated constitute a high risk subgroup in which the prospective evaluation of the efficacy and safety of antithrombotic therapy is warranted.
Original languageEnglish
JournalJournal of thrombosis and thrombolysis
DOIs
Publication statusPublished - 9 Jul 2014

Fingerprint

Dive into the research topics of 'd-Dimer elevation and adverse outcomes'. Together they form a unique fingerprint.

Cite this